Valneva logo

Valneva

Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya

637 employees · est. 2013 · Saint-herblain, France

VS
Verovaccines logo

Verovaccines

VEROVACCiNES creates affordable animal vaccines through innovative technology, with the ability to combine multiple antigens in one vaccine.

2-10 employees · est. 2017

Valneva is the older company (2013 vs 2017); Valneva is the larger of the two.

Side-by-Side Comparison

Valneva Verovaccines
Founded
2013 older 2017
Headquarters
Saint-herblain, France Not tracked yet
Employees
637 larger 2-10
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Pharmaceutical
Funding Stage
Grant Series B
Total Funding
$720.10M $3.10M
Funding Rounds
15 3
Services
Vaccine Research and Development, Manufacturing of Vaccines, Commercialization of Vaccines, Marketing and Distribution Not tracked yet
Target Customers
Healthcare Providers, Travelers, Health Organizations, Governments, Investors Not tracked yet
Taxonomy
Specialty Vaccines, Infectious Disease Prevention, Prophylactic Vaccines, Vaccine Modalities, First-in-Class Vaccines, Only-in-Class Vaccines, Lyme Disease Vaccine, Chikungunya Vaccine, Travel Vaccines, Vaccine R&D, Vaccine Manufacturing, Clinical Development, Public Health Threats, Pfizer Partnership, Zika Virus Vaccine Animal Vaccines, Innovative Technology, Subunit Marker Vaccines, Multivalent Vaccines, Cost-Effective Manufacturing, Combination Vaccine, Thermostability, IP, Veterinary Pharmaceuticals, Collaborations
Website
valneva.com verovaccines.org
Valneva logo

About Valneva

Valneva, founded in 2013, is a France-based specialty vaccine company renowned for addressing infectious diseases with significant unmet needs. With a forward-thinking approach, the company prides itself on offering first-, best-, or only-in-class vaccine solutions. Their portfolio includes the worl...

Verovaccines logo

About Verovaccines

Verovaccines is a biotechnology startup dedicated to creating affordable animal vaccines through innovative technology, with the ability to combine multiple antigens in one vaccine. The company's proprietary technology offers an effective and economical means of developing vaccines, reducing immuniz...

We will tell you when either one moves

BounceWatch watches Valneva and Verovaccines for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Valneva and Verovaccines — by email.

Frequently Asked Questions

Valneva — Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya. Verovaccines — VEROVACCiNES creates affordable animal vaccines through innovative technology, with the ability to combine multiple antigens in one vaccine.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Valneva has raised $720.10M while Verovaccines has raised $3.10M.
Valneva and Verovaccines operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Valneva with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Valneva on 11 Mar 2026, and Verovaccines on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy